Longitude Capital Partners II, LLC Insider Trading
Get free email notifications about insider trading for Longitude Capital Partners II, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners II, LLC. Longitude Capital Partners II, LLC is a 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and a in Tricida, Inc. ($TCDA) and a 10% Owner in Aimmune Therapeutics, Inc. ($AIMT) and a 10% Owner in Aptinyx Inc. ($APTX).
Address: 800 EL CAMINO REAL SUITE 220 MENLO PARK 94025 CA
Companies in which Longitude Capital Partners II, LLC is an Insider
Aimmune Therapeutics, Inc.
Trading Symbol: AIMTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners II, LLC: 10% Owner
Holdings: 6,013,134 shares
Current Value: $112,205,080
Latest Transaction: Dec 01 2016
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aptinyx Inc.
Trading Symbol: APTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners II, LLC: 10% Owner
Holdings: 1,047,450 shares
Latest Transaction: Jun 26 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kala Pharmaceuticals, Inc.
Trading Symbol: KALAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners II, LLC: 10% Owner
Holdings: 2,055,946 shares
Latest Transaction: Jul 27 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tricida, Inc.
Trading Symbol: TCDAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners II, LLC:
Holdings: 2,431,511 shares
Latest Transaction: Jul 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Longitude Capital Partners II, LLC
Sentiment: All, AIMT, APTX, KALA, TCDA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Option Exercise | C | 0.00 | 1,817,447 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Option Exercise | C | 0.00 | 1,817,447 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Option Exercise | C | 0.00 | 9,677,419 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Option Exercise | C | 0.00 | 9,677,419 | 0 | 0 | ||
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Buy | P | 19.00 | 131,579 | 2,500,001 | 3,019,734 | 2.9 M to 3 M (+4.56 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Buy | P | 19.00 | 131,579 | 2,500,001 | 3,019,734 | 2.9 M to 3 M (+4.56 %) | |
Jul 02 2018 | TCDA | Tricida, Inc. | Longitude Capital Partners II, ... | Buy | C | 0.00 | 456,644 | 0 | 2,888,155 | 2.4 M to 2.9 M (+18.78 %) |
View all Longitude Capital Partners II, LLC insider transactions.